Read article – Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, and Michael Heinz, an assistant professor of psychiatry, are featured in an article about the first-ever clinical trial of a therapy chatbot powered by generative AI—a technology that may someday help relieve the lack of access to mental health providers. (Picked up by France 24, Yahoo! Tech, ET HealthWorld, The News.)
Articles by: Geisel Communications
Making Their Voices Heard: Dartmouth Students Visit Capitol Hill for Global Health Education Advocacy
Dartmouth students, Kaveri Krishnamoorthy D’28, Shandy Ndjigue MPH’25, and Olivia Schneider MPH’25, traveled to Capitol Hill in late March with Geisel School of Medicine’s Lisa V. Adams MED’90, Center for Global Health Equity (CGHE) director and others to meet with congressional representatives to advocate for global health education and training.
Is Brown Rice Actually Healthier Than White Rice? – The Washington Post
Read article – Margaret Karagas, a professor and chair of the department of epidemiology, is quoted in an article about the levels of arsenic in white rice and brown rice.
Generative AI Chatbot Delivers Great Results for Mental Health. Is ‘Therabot’ the Future? (Audio) – Depresh Mode with John Moe
Read article – An extended interview with Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, about the first-ever clinical trial of a generative-AI therapy chatbot—a technology that may someday help relieve the lack of access to mental health providers. “We want to provide something that is a strong evidence-based treatment for folks that generally don’t have it,” Jacobson said.
Federal Funds Were the Lifeblood of U.S Scientific Discovery. Where Will the Money Come From Now? – The Boston Globe
Read article – Jacob Borodovsky, a senior research scientist at the Center for Technology and Behavioral Health and the Department of Biomedical Data Science, is quoted in an article about researchers having to seek new ways to maintain or diversify their funding sources as the White House continues to target universities and research programs. “Really, the only institution that would fund my kind of work is the government because they have a public health mandate,” Borodovsky said.
Can a Chatbot Treat Depression? (Audio) – What’s Your Problem? Podcast
Read article – An extended interview with Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, about the first-ever clinical trial of a generative-AI therapy chatbot—a technology that may someday help relieve the lack of access to mental health providers. “There’s just a huge volume of need and not enough people to go around,” Jacobson said.
Can AI Chatbots Help With Mental Health Treatment? – Theravive
Read article – Nicholas Jacobson, associate professor of biomedical data science and psychiatry, talks about the first clinical trial of a gen-AI therapy chatbot conducted on Therabot, software developed in his lab. “We chose this area because we seek to have real world impacts and there is a massive shortage of providers,” Jacobson said.
First-in-Class Prescription Digital Therapeutic Effective for Episodic Migraine – Medscape
Read article – Features comments by Stewart Tepper, a clinical professor of neurology, who served as a co-investigator in a clinical trial for a novel prescription digital therapeutic, CT-132 by Click Therapeutics, that has shown to significantly reduce monthly migraine days in individuals with episodic migraine. “It’s a way of enabling people to access various state-of-the-art behavioral techniques to use alongside their existing medication to offer additional relief,” said Tepper.
Could AI Replace Your Therapist? New Research Suggests the Technology Could Play a Role in Mental Health Care – Philly Voice
Read article – Nicholas Jacobson, an associate professor of biomedical data science and psychiatry, and Michael Heinz, an assistant professor of psychiatry, are featured in an article about Therabot. “Therabot is not limited to an office and can go anywhere a patient goes,” Heinz said. “It was available around the clock for challenges that arose in daily life and could walk users through strategies to handle them in real time. But the feature that allows AI to be so effective is also what confers its risk — patients can say anything to it, and it can say anything back.”
Angelo E. Volandes, MD, MPH, Appointed Second Anna Gundlach Huber Professor in Medicine
The Geisel School of Medicine at Dartmouth has named Angelo E. Volandes, MD, MPH, as the second Anna Gundlach Huber Professor in Medicine. Volandes, a professor of medicine at Geisel, clinician-investigator, and nationally recognized expert in patient-centered decision-making at Dartmouth Health, will serve a four-year term.

